The impact of diabetic nephropathy and severe diabetic retinopathy on chronic limb threatening ischemia risk in individuals with type 1 diabetes: a nationwide, population study

[1]  Y. Zaid,et al.  Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis. , 2019, Current research in translational medicine.

[2]  D. Gordin,et al.  The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up , 2018, Diabetes Care.

[3]  Merlin C. Thomas,et al.  Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes , 2018, Diabetes, obesity & metabolism.

[4]  Wei Wang,et al.  Diabetic Retinopathy: Pathophysiology and Treatments , 2018, International journal of molecular sciences.

[5]  Jennifer K. Sun,et al.  Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes , 2018, Diabetes Care.

[6]  D. Gordin,et al.  Prognosis and Its Predictors After Incident Stroke in Patients With Type 1 Diabetes , 2017, Diabetes Care.

[7]  P. Romano,et al.  Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data. , 2016, Journal of vascular surgery.

[8]  J. Hafner Calciphylaxis and Martorell Hypertensive Ischemic Leg Ulcer: Same Pattern - One Pathophysiology , 2016, Dermatology.

[9]  M. Woodward,et al.  Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes , 2016, Diabetes Care.

[10]  B. Zee,et al.  Prospective Association between Diabetic Retinopathy and Cardiovascular Disease-A Systematic Review and Meta-analysis of Cohort Studies. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[11]  J. Beckman,et al.  Vascular Complications of Diabetes. , 2016, Circulation research.

[12]  Milan Sonka,et al.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus , 2016, Proceedings of the National Academy of Sciences.

[13]  S. Hadjadj,et al.  Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes , 2016, Cardiovascular Diabetology.

[14]  P. Norman,et al.  Temporal trends in initial and recurrent lower extremity amputations in people with and without diabetes in Western Australia from 2000 to 2010. , 2015, Diabetes research and clinical practice.

[15]  V. Aboyans,et al.  Epidemiology of peripheral artery disease. , 2015, Circulation research.

[16]  Dong Zhao,et al.  High Prevalence of Lower Extremity Peripheral Artery Disease in Type 2 Diabetes Patients with Proliferative Diabetic Retinopathy , 2015, PloS one.

[17]  Minshan Jiang,et al.  Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis , 2015, British Journal of Ophthalmology.

[18]  P. M. Lang,et al.  Reduced intraepidermal nerve fiber density in patients with chronic ischemic pain in peripheral arterial disease , 2014, PAIN®.

[19]  D. Gordin,et al.  Different Risk Factor Profiles for Ischemic and Hemorrhagic Stroke in Type 1 Diabetes Mellitus , 2014, Stroke.

[20]  R. Sund Quality of the Finnish Hospital Discharge Register: A systematic review , 2012, Scandinavian journal of public health.

[21]  A. Davies,et al.  Chapter V: Diabetic foot. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[22]  T. Elgzyri,et al.  Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. , 2011, Journal of vascular surgery.

[23]  Deepak L. Bhatt,et al.  Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). , 2010, The American journal of cardiology.

[24]  Caminiti Maurizio,et al.  Evaluation of Feasibility of Ankle Pressure and Foot Oxymetry Values for the Detection of Critical Limb Ischemia in Diabetic Patients , 2010 .

[25]  M. Kibbe,et al.  Critical limb ischemia. , 2010, Journal of vascular surgery.

[26]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[27]  A. Morabito,et al.  Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia , 2009, Diabetes Care.

[28]  P. Sparén,et al.  Risks of Nontraumatic Lower-Extremity Amputations in Patients with Type 1 Diabetes , 2008, Diabetes Care.

[29]  K. Kaski,et al.  Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes , 2008, Diabetes.

[30]  Jeroen J. Bax,et al.  A prognostic risk index for long-term mortality in patients with peripheral arterial disease. , 2007, Archives of internal medicine.

[31]  L. Uccioli,et al.  High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study , 2006, Diabetologia.

[32]  Merlin C. Thomas,et al.  Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.

[33]  A. Eskelinen,et al.  Lower limb amputations in Southern Finland in 2000 and trends up to 2001. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[34]  K. Forrest,et al.  Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. , 2002, Metabolism: clinical and experimental.

[35]  T. Orchard,et al.  Can clinical factors estimate insulin resistance in type 1 diabetes? , 2000, Diabetes.